Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023 Pharmaceutical Investing
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider Pharmaceutical Investing
FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI Life Science Investing
FDA Approves Merck's KEYTRUDA® in Combination With Padcev® for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy Pharmaceutical Investing
Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders Pharmaceutical Investing
Neoadjuvant Opdivo with Chemotherapy Demonstrates Long-Term, Durable Clinical Benefits for Patients with Resectable Non-Small Cell Lung Cancer at Three Years in the CheckMate -816 Trial Pharmaceutical Investing
